+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mucin 1"

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Mucin 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Mucin 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 92 Pages
  • Global
From
Mucin 1 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Mucin 1 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 86 Pages
  • Global
From
Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD2 - Product Thumbnail Image

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD2

  • Report
  • March 2019
  • 90 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Mucin 1 (MUC1) is a transmembrane glycoprotein that is overexpressed in many types of cancer, including breast cancer. It is a potential target for therapeutic intervention, and several drugs have been developed to target MUC1 in breast cancer. These drugs are designed to block the activity of MUC1, which can help to reduce the growth and spread of cancer cells. The MUC1 market for breast cancer drugs is a rapidly growing field, with many companies developing new treatments. These treatments are designed to target MUC1 in order to reduce the growth and spread of cancer cells. Companies in this market include AstraZeneca, Merck, Pfizer, Novartis, and Roche. Show Less Read more